Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.
Why would any healthy person, newly diagnosed with cancer, elect not to undergo curative treatment? Newly diagnosed prostate cancer patients presented with the option of active surveillance often ask ...
A newly developed long-term prediction model demonstrated greater accuracy in estimating prostate cancer–specific mortality compared with existing risk assessment tools. Unlike traditional ...
AACR 2022 Genetically Adjusted PSA May Improve Prostate Cancer Screening A validated genetic score can adjust PSA values to reduce overdiagnosis of prostate cancer and help distinguish clinically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results